Amlodipine Teva

Quick links to important sections

Amlodipine Teva

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amlodipine Teva

Amlodipine Teva is a synthetic compound defined as a prescription-only medicine that provides foundational support for the circulatory system. It is classified as a single-ingredient product designed for chronic management due to its sustained action. As a formulation developed by Teva Pharmaceutical Industries, it represents a specific commercial version of the globally recognized active pharmaceutical ingredient.

Property Description
Active ingredient Amlodipine (commonly as besilate)
Form Tablet (for oral use)
Pharmacological class Calcium Channel Blocker (CCB)
General mechanism Vasodilation (widening of blood vessels)
Origin Synthetic compound

What Type of Medicine is Amlodipine Teva?

Amlodipine Teva is a type of medication known as a Calcium Channel Blocker (CCB), specifically falling into the dihydropyridine subclass. Its sole active ingredient is Amlodipine, which is the International Nonproprietary Name (INN) for the compound. This substance is commercially formulated into a tablet for oral administration. The specific formulation uses the salt Amlodipine besilate to ensure its stability and proper absorption within the digestive system. This classification places it among agents that primarily act by affecting the function of calcium channels within the body's vascular system, distinguishing it from other types of antihypertensive drugs like beta-blockers or ACE inhibitors.


Amlodipine Teva: Composition and General Purpose

The medication’s composition consists of the active ingredient, Amlodipine, combined with various solid pharmaceutical excipients necessary to form the easily swallowed tablet. The general purpose of Amlodipine is achieved through its primary physiological action of promoting vasodilation, which is the widening of blood vessels. By facilitating vascular relaxation, the medicine reduces the muscular tension in the arterial walls, leading to a decrease in the systemic pressure or resistance against which the heart must pump blood. This action is central to supporting effective, stable circulatory function and easing the overall workload on the heart muscle. The Calcium Channel Blocker mechanism is recognized for its role in stabilizing blood vessel tone. It is classified as a long-acting dihydropyridine agent.

What side effects are possible with Amlodipine Teva?

Possible Side Effects and Safety Information

Official regulatory documents classify the possible adverse effects of Amlodipine Teva based on how frequently they are reported. These effects are systematically grouped by the body system affected (System-Organ-Class).


Frequency-Classified Adverse Reactions

The most frequent documented adverse reactions often relate to the medicine’s primary action of vasodilation (widening of blood vessels):

Classification Examples of Documented Adverse Reactions
Very Common (Affects more than 1 in 10 people) Peripheral oedema (swelling, typically of ankles), Headache.
Common (Affects 1 to 10 in 100 people) Fatigue, Dizziness, Somnolence (drowsiness), Palpitations, Nausea, Abdominal pain, Flushing.
Uncommon (Affects 1 to 10 in 1,000 people) Syncope, Hypotension (low blood pressure), Tremor, Dyspnoea (shortness of breath).
Very Rare (Affects less than 1 in 10,000 people) Hepatitis, Jaundice, Pancreatitis, Myocardial Infarction, Arrhythmia, Angioedema (severe allergic swelling).

Some reactions, such as peripheral oedema, are noted in regulatory labels as potentially being dose-related. Headaches are commonly observed, particularly at the beginning of the treatment.


Serious Adverse Reactions and Restrictions

Serious adverse reactions documented in official prescribing information include Myocardial Infarction and Angioedema, which are classified as Very Rare events. The medicine is formally Contraindicated in certain severe cardiovascular conditions, including established severe hypotension, cardiogenic shock, and significant obstruction of the outflow tract of the left ventricle (e.g., high-grade aortic stenosis).


Population-Specific Safety Notes

The regulatory safety profile includes specific considerations for certain patient populations. For older patients and individuals with hepatic impairment, the safety profile notes that lower initial doses may be indicated due to observed decreases in drug clearance.

Overdose and Emergency Response

Overdose Manifestations and Severe Outcomes

Officially documented overdose with Amlodipine is characterized by the drug's potent effects on the vascular system, resulting in profound and prolonged systemic hypotension and excessive peripheral vasodilation. Clinical manifestations listed in regulatory documents include dizziness, fainting (syncope), and a rapid heartbeat (tachycardia). These severe physiological changes can escalate to life-threatening outcomes, including cardiovascular collapse. Continuous monitoring of the cardiac and respiratory systems is explicitly required in these situations.

When Immediate Help Is Required

Government regulatory sources explicitly mandate that individuals seek immediate medical attention upon suspected overdose. Urgent medical help is required when severe symptoms are evident, or if the affected person has collapsed, experiences trouble breathing, or cannot be awakened, necessitating contact with emergency services. This action is critical given the severity of documented cardiovascular events.

Official Management and Antidote Status

Management procedures described in official labeling focus on symptomatic and supportive treatment. No specific antidote is known for Amlodipine overdose. Procedures may include the administration of activated charcoal within two hours of ingestion and measures to restore cardiovascular tone.

Therapeutic Uses of Amlodipine Teva

Main Therapeutic Uses

Amlodipine Teva contains the active substance amlodipine, which belongs to a group of medicines known as calcium antagonists. This medication is primarily used to manage specific cardiovascular conditions related to the heart and blood vessels.

Hypertension (High Blood Pressure)

The primary use of Amlodipine Teva is the treatment of high blood pressure. In patients with hypertension, the medicine works by relaxing the walls of the blood vessels. This allows blood to pass through them more easily, which results in a reduction of blood pressure levels.

Coronary Artery Disease and Angina

Amlodipine Teva is also used to treat certain types of chest pain, known as angina. It is prescribed for:

  • Stable Angina: Chronic chest pain typically brought on by physical exertion or stress.
  • Prinzmetal’s or Variant Angina: A rarer form of angina caused by spasms of the coronary arteries.

In cases of angina, the medication works by improving the blood supply to the heart muscle, allowing it to receive more oxygen. This helps to prevent the onset of chest pain.

Benefits of Treatment

Vascular Relaxation

By inhibiting the movement of calcium into the muscle cells of the arterial walls, the medication prevents these vessels from constricting. This systemic relaxation of the blood vessels is the mechanism by which the medicine helps maintain cardiovascular stability.

Long-term Management

Amlodipine Teva is designed for long-term management rather than the immediate relief of an acute attack of chest pain. Consistent use as part of a broader management plan helps to keep blood pressure controlled throughout the day and reduces the frequency of angina episodes.

Eligibility and Restrictions for Use

Who can and cannot use Amlodipine Teva?

The population eligibility for Amlodipine Teva is strictly defined by regulatory authorities and based on absolute contraindications and specific age or condition-related restrictions.

Populations for Whom Use is Contraindicated

Use of Amlodipine is formally contraindicated and must be avoided in patients with a known hypersensitivity to Amlodipine, other dihydropyridine derivatives, or any of the product’s excipients. It is also prohibited for patients experiencing severe hypotension, various forms of shock (including cardiogenic shock), certain obstructions of the left ventricular outflow tract (e.g., high-grade aortic stenosis), and those with haemodynamically unstable heart failure after a heart attack.


Eligibility and Restrictions

Population Group Eligibility Status (Regulatory Wording)
Adults Established Use for hypertension and angina.
Children (6 to 17 years) Established Use for hypertension only. Safety is not established for use in children under 6 years of age.
Hepatic Impairment Use requires caution; a lower starting dose is often suggested due to the drug's prolonged half-life.
Pregnancy/Lactation Safety in human pregnancy is not established. Use during breastfeeding is not recommended as Amlodipine is transferred into breast milk.

No dosage adjustment is typically required for patients with renal impairment, but caution is advised in cases of severe obstructive coronary artery disease.

What should I know about interactions with other medicines?

Amlodipine Teva (amlodipine) can interact with a variety of other medicines and products, which may alter the effectiveness of either drug or increase the risk of side effects. It is important to inform your doctor about all medicines you are taking, including over-the-counter drugs, supplements, and herbal remedies.

Medicines that May Increase Amlodipine’s Effect

Amlodipine is metabolized by the enzyme CYP3A4. Taking medicines that inhibit this enzyme can increase the concentration of amlodipine in the blood, potentially leading to excessive blood pressure lowering (hypotension) and increased edema. These include:

  • Certain Antifungal Agents: Ketoconazole, Itraconazole
  • Protease Inhibitors for HIV: Ritonavir, Indinavir
  • Certain Antibiotics: Erythromycin, Clarithromycin
  • Other Calcium Channel Blockers: Diltiazem, Verapamil (may also cause additive effects on heart rate and rhythm)
Drug Type Example Substances
Immunosuppressant Ciclosporin (amlodipine may increase its levels)
Cholesterol-lowering drug Simvastatin (amlodipine increases its level; dose of Simvastatin should typically not exceed 20 mg daily)

Medicines that May Decrease Amlodipine’s Effect

Medicines that induce the CYP3A4 enzyme can decrease amlodipine concentrations in the blood, potentially reducing its blood pressure-lowering effect. These include:

  • Tuberculosis Treatment: Rifampicin
  • Certain Anti-epileptic Drugs: Carbamazepine, Phenobarbital, Phenytoin

Other Important Interactions

  • Other Antihypertensive Agents: Concurrent use with other blood pressure medicines (e.g., beta-blockers, ACE inhibitors) may result in an additive hypotensive effect.
  • Grapefruit Juice: Consumption of grapefruit or grapefruit juice should be avoided as it can increase the concentration of amlodipine and enhance its effects.

Mechanism of Action

Selective L-Type Calcium Channel Blockade

Amlodipine's mechanism begins with its role as a selective blocker of the Voltage-dependent L-type Calcium Channel ( L-type Ca^2+ channel), which are highly concentrated in the arterial muscle walls. This targeted interaction inhibits the transmembrane flow of Ca^2+ ions, which are essential for cellular contraction, thus reducing the ability of the vascular smooth muscle cells to contract.

Cascade: Reduction of Systemic Vascular Resistance

By limiting the influx of calcium, the drug causes significant vasodilation (widening) throughout the peripheral circulation. This relaxation directly produces a decrease in Total Peripheral Resistance (TPR), which reduces the mechanical resistance against ventricular ejection.

Kinetics: Sustained, Gradual Modulation

The characteristic of Amlodipine’s mechanism is its slow and sustained binding kinetics at the channel receptor site. This slow, sustained interaction profile dictates a gradual onset of effect on blood vessel tone, supporting a prolonged alteration of systemic resistance.

Dosage and Administration Information

Amlodipine Teva is strictly intended for oral administration and is taken once daily, a pattern supported by its long duration of action. The medication is formulated in tablets available in strengths of 2.5 mg, 5 mg, and 10 mg. The standard initial dose for the management of hypertension and angina in adults is 5 mg taken once daily. The dose may be adjusted based on needs, up to a maximum daily dose of 10 mg.

The titration of the dose proceeds slowly, with a requirement to assess the response over a minimum period of 7 to 14 days before any increase is made. Administration is flexible regarding food; the dose can be taken with or without food but should be maintained at a consistent time each day.

Specific initial dosing instructions apply to certain groups. Therapy for older adults, or individuals with hepatic impairment, is generally started at the lower dose of 2.5 mg once daily. For pediatric patients (ages 6 to 17) being treated for hypertension, the starting dose is 2.5 mg once daily, with a prescribed maximum daily limit of 5 mg daily. If a single dose is missed, it should be taken as soon as it is remembered, unless it is nearly time for the next scheduled dose, in which case the missed dose is skipped to prevent taking a double amount. The entire protocol defines a long-term treatment strategy for chronic cardiovascular management.

Recent Clinical Evidence

Research evidence / Overview of Studies for Amlodipine Teva

Evidence for Use in High Blood Pressure (Hypertension)

Research for Amlodipine has focused heavily in research exploring high blood pressure, a condition characterized by physiological strain. This evidence primarily comes from large-scale, long-term Randomized Controlled Trials (RCTs), which are considered the highest standard of clinical investigation. These trials examined Amlodipine alongside placebo or other active comparator agents. Outcomes monitored in these studies included not just the change in blood pressure numbers, but also long-term results related to Major Adverse Cardiovascular Events (MACE), such as stroke and heart attack.

Research explored changes in blood pressure measurements in the observed adult populations over time. Findings describe patterns observed in these studies, including variations in the rate of these events measured in groups that received Amlodipine versus those that received certain non-CCB drugs. The data show patterns related to blood pressure metrics that were observed across the duration of these long-term RCTs.

Evidence for Use in Angina and Coronary Artery Disease

Amlodipine was evaluated in research exploring outcomes related to conditions characterized by fluctuating or episodic manifestations, specifically Chronic Stable Angina and Vasospastic Angina (chest pain). Research examined how the medication performed in controlled clinical trials alongside placebo or other antianginal treatments. These studies were used in research exploring how symptoms change over time, focusing on outcomes related to physical discomfort and outcomes reflecting daily functioning or activity level.

Studies monitored changes in functional capacity, with measurements reported during treadmill exercise testing. Evidence contributes to understanding symptom patterns, and some studies involving patients with underlying coronary artery disease explored the relationship between Amlodipine and clinical events, such as the need for hospital stay due to unstable angina.

Identified Evidence Gaps and Areas of Uncertainty

While Amlodipine has been extensively studied, the evidence landscape still contains specific gaps. Comparative evidence is lacking for head-to-head outcomes against many newer classes of high blood pressure and angina treatments. Data for certain groups, particularly those with rare or severe co-existing cardiac, hepatic, or renal conditions, remain insufficient for drawing broad conclusions, as these patients were often excluded or underrepresented in the primary trials.

Frequently Asked Questions (FAQ)

Common questions about Amlodipine Teva (FAQ)


Q: What is Amlodipine Teva used for?

A: Amlodipine Teva is a calcium channel blocker used to treat high blood pressure (hypertension) and chest pain (angina, including Prinzmetal's or variant angina).

  • When treating high blood pressure, it helps prevent strokes, heart attacks, and kidney problems.
  • When treating angina, it helps increase blood flow to the heart muscle, relieving chest pain.

Q: How does Amlodipine Teva work?

A: Amlodipine Teva works by relaxing and widening your blood vessels. This action has two main benefits:

  1. For high blood pressure: By widening blood vessels, the blood can flow more easily, which lowers the overall blood pressure.
  2. For angina (chest pain): By relaxing the blood vessels around the heart, it increases the supply of blood and oxygen to the heart muscle, which helps prevent chest pain.

Q: What are the most common side effects of Amlodipine Teva?

A: The most common side effects are generally mild and may include:

  • Swelling of the ankles or feet (edema)
  • Headache
  • Tiredness or fatigue
  • Dizziness
  • Flushing (a feeling of warmth or redness in the face, neck, or chest)

If you experience persistent or bothersome side effects, you should speak with your healthcare provider.


Q: Can I stop taking Amlodipine Teva once my blood pressure is normal?

A: No, you should not stop taking Amlodipine Teva without first talking to your healthcare provider.

  • Amlodipine Teva manages high blood pressure and angina but does not cure them. Stopping the medication abruptly, even if your blood pressure readings are normal, can cause your blood pressure to rise sharply (rebound hypertension) or cause your angina to worsen.
  • It is essential to continue taking the medication exactly as prescribed to keep your condition controlled.

Q: Does Amlodipine Teva interact with grapefruit or grapefruit juice?

A: Yes, grapefruit or grapefruit juice can potentially interact with Amlodipine Teva.

  • Grapefruit can increase the amount of amlodipine your body absorbs, which may increase the risk of side effects such as low blood pressure and dizziness.
  • It is generally recommended to avoid consuming grapefruit products while taking this medication. You should discuss your diet with your healthcare provider or pharmacist.

How should Amlodipine Teva be stored and disposed of?

How to Store and Dispose of Amlodipine

The storage and disposal requirements for Amlodipine are defined by official regulatory standards to ensure product stability and public safety.

Official Storage Conditions

Amlodipine tablets must be stored at controlled room temperature, typically 20 C to 25 C. It is essential to protect the medication from excessive heat, light, and moisture. Always keep the tablets in the original container, which should be tightly closed and light-resistant, and avoid storing them in humid areas like the bathroom.

Handling and Child Safety

To prevent accidental ingestion, the medication must be kept out of the reach and sight of children, ideally secured in a high, locked location.

Disposal Instructions

When disposal is necessary, the preferred method is a drug take-back program. If one is unavailable, follow governmental instructions: mix the medicine with an inedible substance (e.g., dirt or cat litter), place the mixture in a sealed bag, and discard it in the household trash. Do not flush Amlodipine down the toilet, as official documents advise against environmental release.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amlodipine Teva found in:

A-Z Index: